PCNA and neoplasm: In parallel with the decreased tumor growth, a lower expression level of proliferating cell nuclear antigen (PCNA) was observed in Sal-B treated and doxorubicin treated tumor xenografts than in untreated MDA-MB-231 tumor xenografts (Figure 3B).